Did you know the global GLP-1 market, featuring drugs like Ozempic, could surpass $100 billion by 2030? Originally developed to treat diabetes, these therapies are now reshaping weight management and redefining biotechnology. In this episode of Tech4Sight, Diana Daniels hosts Glen Travers, a biotech pioneer, to discuss the innovations revolutionizing global health. Here’s what you’ll learn: • 🚀 How GLP-1 therapies are transforming obesity and diabetes care. • 🧬 The connection between biotechnology and lifestyle changes. • 💡 The biggest challenges facing the biotech industry—and how to overcome them. • 🔮 Bold predictions for metabolic health and the future of healthcare. Glen shares unique insights from decades of experience at the intersection of science, investment, and technology. This episode is a must-listen for leaders and innovators eager to explore the future of health. 🎧 Tune in now and discover how biotech is shaping a healthier tomorrow! #Podcast #Biotechnology #MetabolicHealth #Innovation #Ozempic #GLP1 #FutureOfHealthcare #techpodcast #tech4sight #podcast #spotify #amazonmusic #podimo #mustwatch #podcastshow #youtubemusic #youtubepodcast #youtubepopular #viral

The race to become the Factory of the World. Ah, the 1980s, a decade of neon lights, cassette tapes, and revolutionary change.

The property management software used by many corporate landlords, RealPage, is deploying AI to artificially inflate rental prices in the United States by more than $3.6 billion annually, according to...